Pluri Inc. Investment Owned, Balance, Principal Amount
Pluri Inc. (PLUR) had Investment Owned, Balance, Principal Amount of $22.98 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Schedule of Investments
us-gaap:InvestmentOwnedBalancePrincipalAmount · last filed 2026-05-14
- 2026-03-31: Investment Owned, Balance, Principal Amount $22.98M.
- 2025-12-31: Investment Owned, Balance, Principal Amount $23.48M.
- 2025-09-30: Investment Owned, Balance, Principal Amount $23.48M.
- 2025-06-30: Investment Owned, Balance, Principal Amount $23.46M.
| Period end | Investment Owned, Balance, Principal Amount |
|---|---|
| 2026-03-31 | $22.98M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $23.48M 10-Q · filed 2026-02-12 |
| 2025-09-30 | $23.48M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $23.46M 10-K · filed 2025-09-17 |
| 2025-03-31 | $21.64M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $20.82M 10-Q · filed 2025-02-11 |
| 2024-09-30 | $22.39M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $21.39M 10-K · filed 2024-09-18 |
| 2024-03-31 | $21.62M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $22.12M 10-Q · filed 2024-02-12 |
| 2023-09-30 | $21.20M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $21.72M 10-K · filed 2023-09-12 |
| 2023-03-31 | $21.75M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $21.33M 10-Q · filed 2023-02-13 |
| 2022-09-30 | $19.68M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $20.78K 10-K · filed 2022-09-21 |
| 2022-03-31 | $22.19M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $22.64M 10-Q · filed 2022-02-07 |
| 2021-09-30 | $23.14M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $23.77K 10-K · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |